1311 related articles for article (PubMed ID: 33528827)
1. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
Simani L; Ramezani M; Darazam IA; Sagharichi M; Aalipour MA; Ghorbani F; Pakdaman H
J Neurovirol; 2021 Feb; 27(1):154-159. PubMed ID: 33528827
[TBL] [Abstract][Full Text] [Related]
2. Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors?
Mantovani E; Mariotto S; Gabbiani D; Dorelli G; Bozzetti S; Federico A; Zanzoni S; Girelli D; Crisafulli E; Ferrari S; Tamburin S
J Neurovirol; 2021 Aug; 27(4):631-637. PubMed ID: 34341960
[TBL] [Abstract][Full Text] [Related]
3. Fatigue and symptom-based clusters in post COVID-19 patients: a multicentre, prospective, observational cohort study.
Cornelissen MEB; Bloemsma LD; Vaes AW; Baalbaki N; Deng Q; Beijers RJHCG; Noij LCE; Houweling L; Bazdar S; Spruit MA; Maitland-van der Zee AH;
J Transl Med; 2024 Feb; 22(1):191. PubMed ID: 38383493
[TBL] [Abstract][Full Text] [Related]
4. Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial.
Cash A; Kaufman DL
J Transl Med; 2022 Jun; 20(1):295. PubMed ID: 35764955
[TBL] [Abstract][Full Text] [Related]
5. The relationship between posttraumatic stress disorder, illness cognitions, defence styles, fatigue severity and psychological well-being in chronic fatigue syndrome.
Eglinton R; Chung MC
Psychiatry Res; 2011 Jul; 188(2):245-52. PubMed ID: 21600664
[TBL] [Abstract][Full Text] [Related]
6. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Campen CLMCV; Rowe PC; Visser FC
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056336
[No Abstract] [Full Text] [Related]
7. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.
Sorg AL; Becht S; Jank M; Armann J; von Both U; Hufnagel M; Lander F; Liese JG; Niehues T; Verjans E; Wetzke M; Stojanov S; Behrends U; Drosten C; Schroten H; von Kries R
JAMA Netw Open; 2022 Sep; 5(9):e2233454. PubMed ID: 36166227
[TBL] [Abstract][Full Text] [Related]
8. Post-Traumatic Stress Disorder and Complex Post-Traumatic Stress Disorder in People with Long COVID, ME/CFS, and Controls.
Sanal-Hayes NEM; Hayes LD; Mclaughlin M; Berry ECJ; Sculthorpe NF
Am J Med; 2023 Dec; ():. PubMed ID: 38104642
[TBL] [Abstract][Full Text] [Related]
9. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
Toogood PL; Clauw DJ; Phadke S; Hoffman D
Pharmacol Res; 2021 Mar; 165():105465. PubMed ID: 33529750
[TBL] [Abstract][Full Text] [Related]
10. The comorbidity of self-reported chronic fatigue syndrome, post-traumatic stress disorder, and traumatic symptoms.
Dansie EJ; Heppner P; Furberg H; Goldberg J; Buchwald D; Afari N
Psychosomatics; 2012; 53(3):250-7. PubMed ID: 22296866
[TBL] [Abstract][Full Text] [Related]
11. Pain in people with chronic fatigue syndrome/myalgic encephalomyelitis: the role of traumatic stress and coping strategies.
Krzeczkowska A; Karatzias T; Dickson A
Psychol Health Med; 2015; 20(2):210-6. PubMed ID: 25178481
[TBL] [Abstract][Full Text] [Related]
12. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
Sukocheva OA; Maksoud R; Beeraka NM; Madhunapantula SV; Sinelnikov M; Nikolenko VN; Neganova ME; Klochkov SG; Amjad Kamal M; Staines DR; Marshall-Gradisnik S
J Adv Res; 2022 Sep; 40():179-196. PubMed ID: 36100326
[TBL] [Abstract][Full Text] [Related]
13. Neurological features and outcome in COVID-19: dementia can predict severe disease.
Ghaffari M; Ansari H; Beladimoghadam N; Aghamiri SH; Haghighi M; Nabavi M; Mansouri B; Mehrpour M; Assarzadegan F; Hesami O; Sedaghat M; Farahbakhsh M; Lima BS
J Neurovirol; 2021 Feb; 27(1):86-93. PubMed ID: 33417193
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed in Patients with Long COVID.
Tokumasu K; Honda H; Sunada N; Sakurada Y; Matsuda Y; Yamamoto K; Nakano Y; Hasegawa T; Yamamoto Y; Otsuka Y; Hagiya H; Kataoka H; Ueda K; Otsuka F
Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888568
[No Abstract] [Full Text] [Related]
15. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
[TBL] [Abstract][Full Text] [Related]
16. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.
Retornaz F; Rebaudet S; Stavris C; Jammes Y
J Transl Med; 2022 Sep; 20(1):429. PubMed ID: 36153556
[TBL] [Abstract][Full Text] [Related]
17. Meningoencephalitis associated with COVID-19: a systematic review.
Mondal R; Ganguly U; Deb S; Shome G; Pramanik S; Bandyopadhyay D; Lahiri D
J Neurovirol; 2021 Feb; 27(1):12-25. PubMed ID: 33367960
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
[TBL] [Abstract][Full Text] [Related]
19. IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).
Preßler H; Machule ML; Ufer F; Bünger I; Li LY; Buchholz E; Werner C; Beraha E; Wagner F; Metz M; Burock S; Bruckert L; Franke C; Wilck N; Krüger A; Reshetnik A; Eckardt KU; Endres M; Prüss H
Trials; 2024 Mar; 25(1):172. PubMed ID: 38454468
[TBL] [Abstract][Full Text] [Related]
20. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
